We found the expression of TNFRSF4, FOXP3, and TGFB1 mRNA significantly increased in BM samples from CML patients compared with controls (Figure 8, I–K). The gene discussed is TNFRSF4; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.